Table 1 Baseline characteristics of the training set and validation sets
From: Incomplete immune reconstitution and its predictors in people living with HIV in Wuhan, China
Variables | Derivation set | Internal validation set | External validation set |
|---|---|---|---|
Age at ART initiation (years) | 33 (25,49) | 32 (25,48) | 41 (28,51) |
Sex(%) | |||
 Male | 2429(90.7) | 1005(91.0) | 716(81.5) |
 Female | 249(9.3) | 100(9.0) | 162(18.5) |
Marital status(%) | |||
 Married | 786(29.4) | 312(28.2) | 367(41.8) |
 Unmarried | 1892(70.6) | 793(71.8) | 511(58.2) |
Route of HIV exposure(%) | |||
 MSM | 1785(66.7) | 764(69.1) | 522(59.5) |
 Heterosexual transmission | 851(31.8) | 334(30.2) | 345(39.3) |
 Injection drug use | 18(0.7) | 3(0.3) | 4(0.5) |
 Blood transfusion | 3(0.1) | 0(0) | 3(0.3) |
 Others | 21(0.8) | 4(0.4) | 4(0.5) |
Coinfection(%) | |||
 HBsAg +  | 234(8.7) | 105(9.5) | 61(6.9) |
 Anti HCV +  | 54(2.0) | 27(2.4) | 9(1.0) |
 Herpes Zoster | 108(4.0) | 45(4.1) | 30(3.4) |
 PCP | 72(2.7) | 27(2.4) | 17(1.9) |
 Pulmonary infection | 138(5.2) | 62(5.6) | 10(1.1) |
 tumor | 12(0.4) | 3(0.3) | 4(0.5) |
WHO stage(%) | |||
 I | 574(21.4) | 222(20.1) | 504(57.4) |
 II | 1306(48.8) | 559(50.6) | 151(17.2) |
 III | 616(23.0) | 245(22.2) | 167(19.0) |
 IV | 182(6.8) | 79(7.1) | 56(6.4) |
ART initiation regimen(%) | |||
 AZT + 3TC + NVP/EFV | 986(36.8) | 375(33.9) | 0.093 |
 D4T + 3TC + NVP/EFV | 25(0.9) | 10(0.9) | 0.934 |
 TDF + 3TC + NVP/EFV | 1570(58.6) | 674(61.0) | 0.177 |
 TDF + 3TC + LPV/r | 18(0.7) | 10(0.9) | 0.447 |
 Other | 79(2.9) | 36(3.3) | 0.616 |
 ART delay | 1.4(0.9,2.6) | 1.4(0.9,2.7) | 1.4(0.6,6.6) |
 BMI, kg/m | 21.5(19.6,23.4) | 21.3(19.6,23.4) | 21.0(19.1,22.9) |